Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

CareRx (CHHHF) Stock Price & Analysis

CHHHF Stock Chart & Stats

$2.40-$0.00(-0.21%)
At close: 4:00 PM EST
$2.3$2.4$2.5$2.615 Jul4 Aug12 Aug14 Oct
Day’s Range
$2.39 - $2.41
52-Week Range
$2.22 - $2.89
Previous Close
$2.41
Volume
N/A
Average Volume (3M)
3
Market Cap
$152.84M
Enterprise Value
$291.62M
Total Cash (Recent Filing)
$10.05M
Total Debt (Recent Filing)
$76.33M
Price to Earnings (P/E)
7.8
Beta
0.06
Next Earnings
Nov 04, 2026 (Est.)
EPS Estimate
0.03
Last Dividend Ex-Date
Sep 15, 2026
Dividend Yield
2.42%

Bulls Say, Bears Say

Bulls Say

Profitable Growth And Cash Generation

The return to profitability alongside strong revenue growth indicates a materially improved earnings base. Positive free cash flow and high cash conversion provide internal funding for operations, debt service, and selective growth, supporting resilience over the next several quarters.

Large Retirement-bed Contract Win

Adding approximately 3,000 beds expands CareRx’s contracted service base and should increase recurring pharmacy and medication-management revenue. Because management expects the contract to be accretive to consolidated margins over time, it can strengthen scale and earnings visibility.

Improved Balance-sheet Leverage

Leverage has declined substantially from earlier levels, reducing balance-sheet risk and improving financial flexibility. The current debt burden appears manageable relative to operating earnings, leaving CareRx better positioned to fund bed additions and absorb normal business volatility.

Bears Say

Thin Operating Margins

Although CareRx is profitable, its modest operating margins leave limited protection if costs rise or volumes soften. Small changes in reimbursement, service efficiency, or operating expenses can therefore produce disproportionate effects on net income and cash generation.

Ontario Funding Headwind

The funding change creates a defined multi-period revenue and earnings burden rather than a one-quarter disruption. Recovery depends on ward-bed redevelopment and is not expected until late 2027, leaving near-term results exposed to weaker volume economics and delayed recapture.

Lower Liquidity And Higher Net Debt

The decline in cash alongside higher net debt reduces near-term financial flexibility, particularly while margins remain thin and funding pressure affects earnings. Continued investment, debt repayment, and shareholder distributions could compete for internally generated cash.

CareRx News

CHHHF FAQ

What was CareRx’s price range in the past 12 months?
CareRx lowest stock price was $2.22 and its highest was $2.89 in the past 12 months.
What is CareRx’s market cap?
CareRx’s market cap is $152.84M.
When is CareRx’s upcoming earnings report date?
CareRx’s next earnings report is estimated for Nov 04, 2026 (not yet confirmed), which is in 1 day.
How were CareRx’s earnings last quarter?
CareRx released its earnings results on Jul 29, 2026. The company reported $0.007 earnings per share for the quarter, missing the consensus estimate of $0.016 by -$0.009.
Is CareRx overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does CareRx pay dividends?
CareRx pays a Quarterly dividend of $0.016 which represents an annual dividend yield of 2.42%. See more information on CareRx dividends here
What is CareRx’s EPS estimate?
CareRx’s EPS estimate is 0.03.
How many shares outstanding does CareRx have?
CareRx has 63,514,038 shares outstanding.
What happened to CareRx’s price movement after its last earnings report?
CareRx reported an EPS of $0.007 in its last earnings report, missing expectations of $0.016. Following the earnings report the stock price went up 3.722%.
Which hedge fund is a major shareholder of CareRx?
Currently, no hedge funds are holding shares in CHHHF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology